APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.

RedHill Biopharma (RDHL) announced the initiation of a Phase 2 clinical study to evaluate the efficacy of its opaganib candidate in combination ...

All physicians are faced with the challenge of how to help patients with no approved therapies for their diseases. What are ...